Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company had vide its letter dated 23rd June, 2023, intimated about US FDA inspection of Company’s formulations manufacturing facility situated at SEZ Indore, Pithampur (Madhya Pradesh) from 15th June, 2023 to 23rd June, 2023. Ipca Laboratories has informed that this manufacturing facility has now received Establishment Inspection Report classifying the manufacturing facility as ‘Voluntary Action Indicated (VAI) and that that this facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1838.00 |
| Dr. Reddys Lab | 1308.00 |
| Cipla | 1370.85 |
| Zydus Lifesciences | 939.40 |
| Lupin | 2469.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: